Available in 10 markets
Invesco S&P World Health Care ESG UCITS ETF Acc
Invesco S&P World Health Care ESG UCITS ETF Acc is an exchange-traded fund (ETF) from Invesco, traded under the ticker WHCE (ISIN IE000L4EH2K5). One trade buys a whole basket of holdings, so your money is spread out instead of riding on a single company. At its core it is a focused, thematic fund: it concentrates on the health care part…
Opens the screener with this filter applied.
About this fund
What you own
The S&P World ESG Enhanced Health Care Index index is the benchmark this fund aims to copy. By holding it, this fund gives you a stake in around 67 companies across Global in a single purchase.
Dividends
The fund automatically reinvests dividends back into itself, so your holding grows without cash payouts.
Read more
Rolling the dividends straight back in means your money compounds automatically, with nothing for you to reinvest by hand. The flip side is there is no cash income; the growth simply shows up as a higher fund value. Note that reinvested dividends can still be taxable in some countries even though you never receive the cash — the rules depend on where you live.
How it works
The fund actually buys every share in the index it tracks (full replication).
Read more
Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.
Cost
The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.
Read more
For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.
Fund facts
Performance
Growth of $100 invested — the line starts at $100.
End-of-day prices, rebased to a common start so the shapes are comparable. Past performance does not predict future results.
Return, year by year
How bumpy has it been?
The bigger picture
What's inside
The 10 biggest holdings make up 66.1% of the fund — the rest is spread across roughly 57 more companies.
Top 10 holdings
| # | Company | Weight |
|---|---|---|
| 1 | ELI LILLY & CO NPV | 16.8% |
| 2 | ABBVIE INC USD0.01 | 12.4% |
| 3 | MERCK & CO. INC. USD0.5 | 7.3% |
| 4 | GILEAD SCIENCES INC USD0.001 | 4.6% |
| 5 | ASTRAZENECA PLC USD0.25 | 4.6% |
| 6 | NOVARTIS AG-REG CHF0.5 | 4.4% |
| 7 | ROCHE HOLDINGS AG CHF NPV | 4.4% |
| 8 | AMGEN INC USD0.0001 | 4.0% |
| 9 | THERMO FISHER SCIENTIFIC INC USD1 | 3.9% |
| 10 | ABBOTT LABORATORIES NPV | 3.7% |
Where to buy this fund
Set from your language & location — change it if it's wrong.
Where it trades
| Exchange | Ticker | Currency | |
|---|---|---|---|
| LSE | WHCE | USD | ★ Primary |
| CHF listings | |||
| SIX | WHCE | CHF | |
| SIX | WHCECHF | CHF | |
| EUR listings | |||
| Borsa Italiana | WDHE | EUR | |
| Frankfurt | WH2E | EUR | |
| USD listings | |||
| B3 | WHCEL | USD | |
| B3 | WHCGL | USD | |
| BW | WHCECHF | USD | |
| E1 | WHCEEUR | USD | |
| E1 | WHCEUSD | USD | |
| E1 | WHCEGBX | USD | |
| EO | WHCEEUR | USD | |
| EO | WHCEGBX | USD | |
| EO | WHCEUSD | USD | |
| EP | WHCEUSD | USD | |
| EP | WHCEEUR | USD | |
| EU | WHCEEUR | USD | |
| EU | WHCEGBX | USD | |
| EU | WHCEUSD | USD | |
| EZ | WHCEEUR | USD | |
| EZ | WHCEUSD | USD | |
| GD | WH2E | USD | |
| GF | WH2E | USD | |
| GM | WH2E | USD | |
| GS | WH2E | USD | |
| GT | WH2E | USD | |
| GZ | WH2E | USD | |
| L1 | WHCGL | USD | |
| L1 | WHCEL | USD | |
| L3 | WHCGL | USD | |
| L3 | WHCEL | USD | |
| LA | WH2E | USD | |
| London Stock Exchange | WHCE | USD | |
| LSE | WHCG | USD | |
| LU | WH2E | USD | |
| PO | WHCGL | USD | |
| PO | WHCEL | USD | |
| QT | WH2E | USD | |
| S1 | WH2ED | USD | |
| S1 | WHCEL | USD | |
| S1 | WHCEZ | USD | |
| S1 | WHCGL | USD | |
| S4 | WH2ED | USD | |
| SE | WHCE | USD | |
| TH | WH2E | USD | |
| X1 | WHCEEUR | USD | |
| X1 | WHCEGBX | USD | |
| X1 | WHCEUSD | USD | |
| X2 | WHCEUSD | USD | |
| X2 | WHCEGBX | USD | |
| X2 | WHCEEUR | USD | |
| X9 | WHCEEUR | USD | |
| XA | WHCEEUR | USD | |
| XA | WHCEGBX | USD | |
| XA | WHCEUSD | USD | |
| XE | WHCEUSD | USD | |
| XE | WHCEGBX | USD | |
| XE | WHCEEUR | USD | |
| XF | WHCEEUR | USD | |
| XF | WHCEGBX | USD | |
| XF | WHCEUSD | USD | |
| XG | WHCEUSD | USD | |
| XG | WHCEGBX | USD | |
| XG | WHCEEUR | USD | |
| XH | WHCEEUR | USD | |
| XH | WHCEGBX | USD | |
| XH | WHCEUSD | USD | |
| XJ | WHCEUSD | USD | |
| XJ | WHCEGBX | USD | |
| XJ | WHCEEUR | USD | |
| XL | WHCEEUR | USD | |
| XL | WHCEGBX | USD | |
| XL | WHCEUSD | USD | |
| XO | WHCEUSD | USD | |
| XO | WHCEGBX | USD | |
| XO | WHCEEUR | USD | |
| XQ | WHCEEUR | USD | |
| XQ | WHCEGBX | USD | |
| XQ | WHCEUSD | USD | |
| XT | WHCEUSD | USD | |
| XT | WHCEGBX | USD | |
| XT | WHCEEUR | USD | |
| XU | WHCEEUR | USD | |
| XU | WHCEGBX | USD | |
| XU | WHCEUSD | USD | |
| XV | WHCEUSD | USD | |
| XV | WHCEGBX | USD | |
| XV | WHCEEUR | USD | |
| XW | WHCEEUR | USD | |
| XW | WHCEGBX | USD | |
| XW | WHCEUSD | USD | |
| XX | WHCEUSD | USD | |
| XX | WHCEGBX | USD | |
| XX | WHCEEUR | USD | |
| XY | WHCEEUR | USD | |
| XY | WHCEGBX | USD | |
| XY | WHCEUSD | USD | |
| XZ | WHCEEUR | USD | |
| XZ | WHCEGBX | USD | |
| XZ | WHCEUSD | USD | |
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows
Full holdings
As of 2026-10-05 · the fund's own published holdings.
| # | Company | Weight |
|---|---|---|
| 1 | ELI LILLY & CO NPV | 16.8% |
| 2 | ABBVIE INC USD0.01 | 12.4% |
| 3 | MERCK & CO. INC. USD0.5 | 7.3% |
| 4 | GILEAD SCIENCES INC USD0.001 | 4.6% |
| 5 | ASTRAZENECA PLC USD0.25 | 4.6% |
| 6 | NOVARTIS AG-REG CHF0.5 | 4.4% |
| 7 | ROCHE HOLDINGS AG CHF NPV | 4.4% |
| 8 | AMGEN INC USD0.0001 | 4.0% |
| 9 | THERMO FISHER SCIENTIFIC INC USD1 | 3.9% |
| 10 | ABBOTT LABORATORIES NPV | 3.7% |
| 11 | DANAHER CORP USD0.01 | 2.7% |
| 12 | BRISTOL-MYERS SQUIBB CO USD0.1 | 2.4% |
| 13 | MEDTRONIC PLC USD0.1 | 2.3% |
| 14 | PFIZER INC USD0.05 | 2.3% |
| 15 | UNITEDHEALTH GROUP INC USD0.01 | 1.9% |
| 16 | REGENERON PHARMACEUTICALS USD0.001 | 1.6% |
| 17 | STRYKER CORP USD0.1 | 1.4% |
| 18 | EDWARDS LIFESCIENCES CORP USD1 | 1.2% |
| 19 | BOSTON SCIENTIFIC CORP USD0.01 | 1.1% |
| 20 | SANOFI EUR2 | 1.0% |
| 21 | GSK PLC GBP 25.0000 | 0.9% |
| 22 | CSL LTD AUD NPV | 0.9% |
| 23 | AGILENT TECHNOLOGIES INC USD0.01 | 0.9% |
| 24 | TAKEDA PHARMACEUTICAL CO LTD NPV | 0.9% |
| 25 | ESSILORLUXOTTICA EUR0.18 | 0.8% |
| 26 | Elevance Health Inc USD0.01 | 0.8% |
| 27 | CHUGAI PHARMACEUTICAL CO LTD NPV | 0.7% |
| 28 | IDEXX LABORATORIES INC USD0.1 | 0.7% |
| 29 | ARGENX SE NPV | 0.7% |
| 30 | DAIICHI SANKYO CO LTD NPV | 0.7% |
| 31 | TEVA PHARMACEUTICAL IND LTD USD 0.1000 | 0.6% |
| 32 | LONZA GROUP AG-REG CHF1 | 0.6% |
| 33 | HOYA CORP NPV | 0.5% |
| 34 | UCB SA NPV | 0.5% |
| 35 | BECTON DICKINSON AND CO USD1 | 0.5% |
| 36 | COLOPLAST-B DKK1 | 0.5% |
| 37 | ASTELLAS PHARMA INC NPV | 0.4% |
| 38 | Fresenius SE & Co KGaA EUR NPV | 0.4% |
| 39 | MERCK KGAA NPV | 0.3% |
| 40 | Sandoz Group AG CHF 0.05 | 0.3% |
| 41 | ALCON INC CHF0.04 | 0.3% |
| 42 | SHIONOGI & CO LTD NPV | 0.3% |
| 43 | BIONTECH SE-ADR USD NPV ADR | 0.3% |
| 44 | FISHER & PAYKEL HEALTHCARE C NPV | 0.2% |
| 45 | CVS HEALTH CORP USD0.01 | 0.2% |
| 46 | GE HEALTHCARE TECHNOLOG-W/I USD NPV | 0.2% |
| 47 | SIEMENS HEALTHINEERS AG NPV | 0.2% |
| 48 | SWEDISH ORPHAN BIOVITRUM AB SEK0.55 | 0.2% |
| 49 | ROCHE HOLDING AG-BR CHF1 | 0.2% |
| 50 | ONO PHARMACEUTICAL CO LTD NPV | 0.2% |
| 51 | ICON PLC EUR0.06 | 0.2% |
| 52 | EISAI CO LTD NPV | 0.2% |
| 53 | SARTORIUS AG-VORZUG EUR NPV PFD | 0.1% |
| 54 | OLYMPUS CORP NPV | 0.1% |
| 55 | ORION OYJ-CLASS B EUR0.65 | 0.1% |
| 56 | SONIC HEALTHCARE LTD NPV | 0.1% |
| 57 | COCHLEAR LTD NPV | 0.1% |
| 58 | TERUMO CORP NPV | 0.1% |
| 59 | RAMSAY HEALTH CARE LTD NPV | 0.1% |
| 60 | SYSMEX CORP NPV | 0.1% |
| 61 | SARTORIUS STEDIM BIOTECH EUR0.2 | 0.1% |
| 62 | SMITH & NEPHEW PLC GBP 0.2000 | 0.1% |
| 63 | OTSUKA HOLDINGS CO LTD NPV | 0.0% |
| 64 | KYOWA KIRIN CO LTD NPV | 0.0% |
| 65 | Cigna Group/The USD0.01 | 0.0% |
| 66 | SARTORIUS AG NPV | 0.0% |
| 67 | Cash and/or Derivatives | 0.0% |
How it ranks vs peers
Versus the Equity (stocks) · Global · EUR ETFs we track.
Advanced risk
Concentration depth
Roughly 67 companies are held, but the largest names carry most of the weight — so it behaves like ~15 equal-sized positions.
Tilt vs a world tracker
Percentage points over / under a broad world-equity tracker (not a licensed benchmark).
Documents
Similar funds
We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.
| Invesco S&P World Health Care ESG UCITS ETF AccInvescoYou're viewing | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | State Street® SPDR® Portfolio Developed World ex-US ETFSPDRBroader match | iShares MSCI ACWI UCITS ETFiSharesBroader match | |
|---|---|---|---|---|---|---|---|
| Why it's similar | This is the fund on this page. | StocksPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. | StocksAccumulatingPhysical Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksAccumulatingPhysical Tracks a different index in the same category. |
| Index tracked | S&P World ESG Enhanced Health Care Index | MSCI World | MSCI World | MSCI World | MSCI World | S&P Developed Ex-U.S. BMI Index | MSCI ACWI |
| Yearly fee (TER) | 0.18% | 0.30% | 0.30% | 0.20% | 0.20% | 0.03% | 0.20% |
| All-in cost | 0.20% | 0.30% | 0.00% | 0.00% | 0.20% | 0.00% | 0.20% |
| Fund size | €10.9M | €173.7B | €146.5B | €128.1B | €127.6B | €36.5B | €31.4B |
| Domicile | Ireland | Ireland | Ireland | Ireland | Ireland | United States | Ireland |
| Replication | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) |
| 3-yr return p.a. | +6.4% | +16.8% | +17.8% | +18.3% | +17.3% | +17.9% | |
| 5-yr return p.a. | +9.7% | +9.3% | +11.3% | +6.5% | +10.4% | ||
| # holdings | 67 | 1,356 | 1,356 | 1,356 | 1,356 | 2,466 | 1,738 |
The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.
Open the full comparison tool →New to ETFs? Start with the basics →
Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.